BioNexus Gene Lab Corp. Finite-lived Intangible Assets Acquired
BioNexus Gene Lab Corp. (BGLC) reported Finite-lived Intangible Assets Acquired of $450.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2025-05-15
- BioNexus Gene Lab Corp. finite-lived intangible assets acquired for the quarter ending 2025-03-31 was $450.00K.
- BioNexus Gene Lab Corp. finite-lived intangible assets acquired for fiscal 2024 was $450.00K.
| Period end | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|
| 2025-03-31 | $450.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $450.00K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |